In a filing, Arbutus Biopharma Corp revealed its Director McElhaugh Michael J. acquired Company’s shares for reported $0.17 million on Apr 15 ’25. In the deal valued at $3.20 per share,53,114 shares were bought.
Then, Sofia Michael J. bought 250,000 shares, generating $875,000 in total proceeds.
Before that, Sofia Michael J. bought 250,000 shares. Arbutus Biopharma Corp shares valued at $820,000 were divested by the Officer at a price of $3.28 per share.
Jefferies upgraded its Arbutus Biopharma Corp [ABUS] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in late February with a ‘”a Hold”‘ rating. H.C. Wainwright began covering ABUS with “Buy” recommendation on December 17, 2020.
Price Performance Review of ABUS
On Tuesday, Arbutus Biopharma Corp [NASDAQ:ABUS] saw its stock fall -3.66% to $3.16. Over the last five days, the stock has gained 9.72%. Arbutus Biopharma Corp shares have fallen nearly -3.36% since the year began. Nevertheless, the stocks have risen 8.59% over the past one year. While a 52-week high of $4.72 was reached on 02/25/25, a 52-week low of $2.63 was recorded on 04/09/25. SMA at 50 days reached $3.32, while 200 days put it at $3.60.
Levels Of Support And Resistance For ABUS Stock
The 24-hour chart illustrates a support level at 3.09, which if violated will result in even more drops to 3.03. On the upside, there is a resistance level at 3.28. A further resistance level may holdings at 3.41. The Relative Strength Index (RSI) on the 14-day chart is 45.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 49.45%. Stochastics %K at 54.21% indicates the stock is a holding.
How much short interest is there in Arbutus Biopharma Corp?
A steep rise in short interest was recorded in Arbutus Biopharma Corp stocks on 2025-03-31, growing by 1.44 million shares to a total of 9.85 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 8.41 million shares. There was a rise of 14.58%, which implies that there is a positive sentiment for the stock.
